FDA Inspection
Carter BloodCare - AllianceCarter BloodCare - Alliance – FDA Inspection, Feb 1, 2013
Record Details
This FDA Inspection record concerns Carter BloodCare - Alliance, with an inspection on February 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare - Alliance
- Inspection Date
- February 1, 2013
- Product Type
- Biologics
View Company Profile
ID · 86828de2-0988-44d5-928c-fa3b71401f83
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 816572
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare - Alliance
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 29, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare - Alliance
- FDA Inspection 1254697 - 2024-11-15
- FDA Inspection 1101790 - 2019-09-06
- FDA Inspection 1023359 - 2017-07-18
- FDA Inspection 924176 - 2015-04-29
- FDA Inspection 725185 - 2011-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.